Canadian marijuana firm Aurora’s sales surge, losses widen

Just Released! Get realistic market forecasts, state-by-state insights and benchmarks with the new 2024 MJBiz Factbook member program, now with quarterly updates. Make informed decisions.

Aurora Cannabis losses, Canadian marijuana firm Aurora’s sales surge, losses widen

Aurora Cannabis, an Edmonton, Alberta-based cannabis producer, reported fiscal third-quarter revenue of 75 million Canadian dollars ($56 million) – up more than 365% from a year ago.

The company’s net loss grew to CA$158.3 million – up from $19.2 million in the year-ago quarter.

The boost in sales was fueled by growth across its key markets, the company said in a news release.

Revenue attributable to Canada’s adult-use market grew 37% from the previous quarter to $29.6 million. Medical cannabis sales grew to $29 million, up 12% from the previous quarter.

The surging red ink reflects the company’s obligation to revalue the convertible debt it carries on its balance sheet, resulting in losses of CA$101.5 million.

Aurora trades on the New York Stock Exchange under the ticker symbol ACB.

For more analysis and in-depth looks at the investment trends and deals driving the cannabis industry forward, sign up for our premium subscription service, Investor Intelligence.